MKL Share Price | Markel Group, Inc. Stock Analysis & Recommendation

Q: How big is Markel Group, Inc.?

Market Cap: As of Jun 18, Markel Group, Inc. has a market capitalization of 24,636.83 million, categorizing it as a Mid Cap company.Recent Quarterly Performance: For the latest four quarters, Markel Group, Inc. reported net sales of 0.00 million and a consolidated net profit of 1,927.57 million.Balance Sheet Snapshot: As of Dec 24, the company reported shareholder's funds of 16,915.90 million and total assets of 47,345.93 million.

Q: What does Markel Group, Inc. do?

Overview:Markel Group, Inc. is a financial holding company that specializes in underwriting specialty insurance products and operates within the insurance industry, categorized as a mid-cap company.Financial Snapshot:- Most recent Net Profit: 129 Million (Quarterly Results - Mar 2025)- Market-cap: USD 24,636.83 Million (Mid Cap)Key Metrics:- P/E: 14.00- Return on Equity: 10.48%- Price to Book: 1.44Contact Details:- Address: 4521 Highwoods Pkwy, GLEN ALLEN VA: 23060-6148- Tel: 1 804 7470136- Website: https://www.markel.com/

Q: Is Markel Group, Inc. overvalued or undervalued?

As of 30 June 2025, the valuation grade for Markel Group, Inc. moved from expensive to fair, indicating a more favorable assessment of its valuation. The company appears fairly valued based on its current metrics, with a P/E ratio of 14, a Price to Book Value of 1.45, and an EV to Sales ratio of 1.06. In comparison to peers, W.R. Berkley Corp. has a significantly higher P/E ratio of 22.84, while Loews Corp. stands at 15.89, suggesting that Markel is competitively priced within its industry.Despite recent stock performance showing a 1-week decline of 0.99% compared to a 1.05% gain in the S&P 500, Markel has outperformed the index on a year-to-date basis with a return of 12.65% versus 12.22%. Over the past year, Markel's stock has increased by 23.91%, significantly exceeding the S&P 500's 17.14% return. This performance reinforces the notion that Markel Group, Inc. is fairly valued in the current market environment.

Q: Is Markel Group, Inc. technically bullish or bearish?

As of 31 October 2025, the technical trend for Markel Group, Inc. has changed from sideways to mildly bullish. The daily moving averages indicate a bullish stance, while the weekly and monthly MACD readings are mildly bearish. The Bollinger Bands show a mildly bullish trend on the monthly timeframe. However, the KST presents a mixed picture with a bearish weekly signal and a bullish monthly signal. Overall, the technical indicators suggest a mildly bullish outlook, albeit with some caution due to the bearish MACD and KST on the weekly timeframe.In terms of performance, Markel has outperformed the S&P 500 over the past week and year, with returns of 5.23% and 28.27%, respectively, compared to the S&P 500's 0.71% and 19.89%. However, it has lagged behind the benchmark in the 3-year and 5-year periods.

Results Declared: Markel Group, Inc. has declared results on 28 Apr 2026! Click here to unlock the latest financial performance

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

21.25 k

Shareholding (Mar 2026)

FII

16.86%

Held by 318 FIIs

DII

56.2%

Held by 30 DIIs

Promoter

0.13%

How big is Markel Group, Inc.?

22-Jun-2025

As of Jun 18, Markel Group, Inc. has a market capitalization of $24.64 billion, with total assets of $47.35 billion and shareholder's funds of $16.92 billion.

View full answer

What does Markel Group, Inc. do?

22-Jun-2025

Markel Group, Inc. is a mid-cap financial holding company that specializes in underwriting specialty insurance products. As of March 2025, it reported a net profit of $129 million and has a market capitalization of approximately $24.64 billion.

View full answer

Who are in the management team of Markel Group, Inc.?

22-Jun-2025

As of March 2022, the management team of Markel Group, Inc. includes Chairman Steven Markel, Co-CEOs Thomas Gayner and Richard Whitt, Lead Independent Director Stewart Kasen, and Directors A. Lynne Puckett, Mark Besca, K. Bruce Connell, and Diane Leopold. They oversee the company's operations and strategic direction.

View full answer

Is Markel Group, Inc. overvalued or undervalued?

20-Sep-2025

As of June 30, 2025, Markel Group, Inc. is considered fairly valued with a P/E ratio of 14 and has outperformed the S&P 500 year-to-date and over the past year, despite a recent slight decline in stock performance.

View full answer

Is Markel Group, Inc. technically bullish or bearish?

05-Nov-2025

As of October 31, 2025, Markel Group, Inc. shows a mildly bullish trend with daily moving averages indicating bullishness, despite mixed signals from weekly MACD and KST, while outperforming the S&P 500 over the past week and year but lagging in the 3- and 5-year periods.

View full answer

Compare Markel Group, Inc. with Similar Stocks

The Allstate Corp.Chubb Ltd.Berkshire Hathaway, Inc.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Strong Long Term Fundamental Strength with a 15.24% CAGR growth in Net Sales

The company declared very negative results in Mar'25 after flat results in Dec'24

With ROE of 10.48%, it has a fair valuation with a 1.45 Price to Book Value

Mojo Parameters

Stock DNA

Industry

Insurance

Market cap

USD 24,589 Million (Mid Cap)

P/E

12.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

-999,999.00

Return on Equity

0.00%

Price to Book

0.00

Revenue and Profits:

Net Sales:

(Quarterly Results - Mar 2026)

Net Profit:

-204 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-15.06%

6 Months

-11.13%

1 Year

-4.74%

2 Years

12.13%

3 Years

32.06%

4 Years

34.35%

5 Years

48.99%

Markel Group, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

11.24%

EBIT Growth (5y)

-188.90%

EBIT to Interest (avg)

-0.02

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

Tax Ratio

21.44%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

81.69%

ROCE (avg)

0.35%

ROE (avg)

12.49%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

EV to EBIT

28892.81

EV to EBITDA

165.93

EV to Capital Employed

6.71

EV to Sales

1.74

PEG Ratio

Dividend Yield

ROCE (Latest)

ROE (Latest)

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bullish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

No Trend

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2026

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 111 Schemes (26.8%)

Foreign Institutions

Held by 318 Foreign Institutions (16.86%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Mar 2025",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -258.08% vs -87.68% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "43.50",
          "val2": "46.90",
          "chgp": "-7.25%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "50.90",
          "val2": "52.10",
          "chgp": "-2.30%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-204.40",
          "val2": "129.30",
          "chgp": "-258.08%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-96.80%",
          "val2": "83.10%",
          "chgp": "-17.99%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 0.00% vs 0.00% in Dec 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -24.41% vs 35.52% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "347.90",
          "val2": "342.40",
          "chgp": "1.61%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "205.90",
          "val2": "204.30",
          "chgp": "0.78%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2,152.40",
          "val2": "2,847.40",
          "chgp": "-24.41%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "192.60%",
          "val2": "223.40%",
          "chgp": "-3.08%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

43.50

46.90

-7.25%

Interest

50.90

52.10

-2.30%

Exceptional Items

0.00

Consolidate Net Profit

-204.40

129.30

-258.08%

Operating Profit Margin (Excl OI)

-96.80%

83.10%

-17.99%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is -258.08% vs -87.68% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

347.90

342.40

1.61%

Interest

205.90

204.30

0.78%

Exceptional Items

0.00

Consolidate Net Profit

2,152.40

2,847.40

-24.41%

Operating Profit Margin (Excl OI)

192.60%

223.40%

-3.08%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 0.00% vs 0.00% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -24.41% vs 35.52% in Dec 2024

All Annual Results

Company CV

About Markel Group, Inc.

Markel Group, Inc.

Insurance

Markel Corporation is a financial holding company serving a range of markets. The Company's principal business markets and underwrites specialty insurance products. It monitors and reports its ongoing underwriting operations in three segments: U.S. Insurance, International Insurance and Reinsurance. The Company, through its subsidiary Markel Ventures, Inc. (Markel Ventures), owns interests in various industrial and service businesses that operate outside of the specialty insurance marketplace. The U.S. Insurance segment includes all direct business and facultative placements written by its insurance subsidiaries domiciled in the United States. The International Insurance segment includes all direct business and facultative placements written by its insurance subsidiaries domiciled outside of the United States, including its syndicate at Lloyd's of London (Lloyd's). The Reinsurance segment includes all treaty reinsurance written across the Company.

Company Coordinates

Company Details

4521 Highwoods Pkwy , GLEN ALLEN VA : 23060-6148

Tel: 1 804 7470136

https://www.markel.com/

Registrar Details